Related references
Note: Only part of the references are listed.Metformin effects revisited
P. Andujar-Plata et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2012)
Reciprocal Interference Between Insulin and Interferon-alpha Signaling in Hepatic Cells: A Vicious Circle of Clinical Significance?
Lisa Franceschini et al.
HEPATOLOGY (2011)
Inhibition of PTP1B Restores IRS1-Mediated Hepatic Insulin Signaling in IRS2-Deficient Mice
Agueda Gonzalez-Rodriguez et al.
DIABETES (2010)
Clarifying metformin's role and risks in liver dysfunction
Carolyn C. Brackett
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2010)
Treatment of Insulin Resistance with Metformin in Naive Genotype 1 Chronic Hepatitis C Patients Receiving Peginterferon Alfa-2a Plus Ribavirin
Manuel Romero-Gomez et al.
HEPATOLOGY (2009)
Interferon alpha increases metalloproteinase-13 gene expression through a polyomavirus enhancer activator 3-dependent pathway in hepatic stellate cells
Teresa Diaz-Sanjuan et al.
JOURNAL OF HEPATOLOGY (2009)
Insulin-like signaling, nutrient homeostasis, and life span
Akiko Taguchi et al.
ANNUAL REVIEW OF PHYSIOLOGY (2008)
PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling
Xiaoqing Lu et al.
BLOOD (2008)
Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo
Janice M. Zabolotny et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C
Christine Bernsmeier et al.
JOURNAL OF HEPATOLOGY (2008)
Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages
Hongmei Xu et al.
MOLECULAR IMMUNOLOGY (2008)
Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: A randomized trial
Ira M. Jacobson et al.
HEPATOLOGY (2007)
被撤回的出版物: Protein-tyrosine phosphatase 1B-deficient myocytes show increased insulin sensitivity and protection against tumor necrosis factor-α-induced insulin resistance (Retracted article. See vol. 69, pg. 2536, 2020)
Iria Nieto-Vazquez et al.
DIABETES (2007)
Developmental switch from prolonged insulin action to increased insulin sensitivity in protein tyrosine phosphatase 1B-deficient hepatocytes
Agueda Gonzalez-Rodriguez et al.
ENDOCRINOLOGY (2007)
Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice
Inmaculada Garcia-Ruiz et al.
HEPATOLOGY (2006)
Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1
MJ Walsh et al.
GUT (2006)
S-adenosylmethionine and betaine correct hepatitis C virus induced inhibition of interferon signaling in vitro
FHT Duong et al.
HEPATOLOGY (2006)
Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients
M Romero-Gómez et al.
GASTROENTEROLOGY (2005)
PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity
B Liu et al.
NATURE IMMUNOLOGY (2004)
Nucleocytoplasmic shuttling of STAT transcription factors
T Meyer et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2004)
Metformin (glucophage) inhibits tyrosine phosphatase activity to stimulate the insulin receptor tyrosine kinase
W Holland et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes
AM Valverde et al.
DIABETES (2003)
High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C
BL Bressler et al.
HEPATOLOGY (2003)
Metformin rapidly increases insulin receptor activation in human liver and signals preferentially through insulin-receptor substrate-2
JE Gunton et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice
RJ Gum et al.
DIABETES (2003)
Structural and functional genomics and evolutionary relationships in the cluster of genes encoding murine 2 ',5 '-oligoadenylate synthetases
T Mashimo et al.
GENOMICS (2003)
Constitutive expression of SOCS3 confers resistance to IFN-α in chronic myelogenous leukemia cells
I Sakai et al.
BLOOD (2002)
Cytokine signaling in 2002: New surprises in the Jak/Stat pathway
JJ O'Shea et al.
CELL (2002)
SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-α in the adipose tissue of obese mice
B Emanuelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
TYK2 and JAR2 are substrates of protein-tyrosine phosphatase 1B.
MP Myers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Phosphorylation of PTP1B at Ser50 by Akt impairs its ability to dephosphorylate the insulin receptor
LV Ravichandran et al.
MOLECULAR ENDOCRINOLOGY (2001)
Contraindications to metformin therapy in patients with Type 2 diabetes - a population-based study of adherence to prescribing guidelines
AM Emslie-Smith et al.
DIABETIC MEDICINE (2001)
Tumor necrosis factor α attenuates interferon-α signaling in the liver:: involvement of SOCS3 and SHP2 and implication in resistance to interferon therapy
F Hong et al.
FASEB JOURNAL (2001)
Expression of small heat shock protein αB-crystallin is induced after hepatic stellate cell activation
A Lang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2000)
Share Paper
